Financials

  • Market Capitalization 101.7 M
  • Employee 76
  • Founded 2013
  • CEO Jayson Rieger
  • Website www.verrica.com
  • Headquarter Delaware, United States
  • FIGI BBG00L03BYB7
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.95
Price to sales ratio
2.49

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3962
KLRS
Kalaris Therapeutics, Inc. - Common Stock
4.42 USD-0.45%-8.11%-2.64%-56.79%105.16 M USD
3970
ANIX
Anixa Biosciences, Inc. - Common Stock
3.06 USD0.00%+0.99%+19.07%-4.97%104.11 M USD
3984
ICCC
ImmuCell Corporation - Common Stock
11.08 USD+1.74%+8.10%+15.54%+71.25%100.24 M USD
3998
BMEA
Biomea Fusion, Inc. - Common Stock
1.33 USD+0.76%-2.92%+10.83%-31.79%96.16 M USD

Frequently asked questions about Verrica Pharmaceuticals Inc. - Common Stock

What is the Verrica Pharmaceuticals Inc. - Common Stock stock price today?

The current price of Verrica Pharmaceuticals Inc. - Common Stock (VRCA) is 5.92. Over the past 24 hours, the stock has changed by -5.43%. Follow the VRCA chart for real-time price dynamics.

What is the stock ticker of Verrica Pharmaceuticals Inc. - Common Stock?

Verrica Pharmaceuticals Inc. - Common Stock trades under the ticker VRCA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Verrica Pharmaceuticals Inc. - Common Stock stock going up?

VRCA has changed by -1.66% over the last week, +2.07% over the last month, and -1.66% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Verrica Pharmaceuticals Inc. - Common Stock net income for the last quarter?

Verrica Pharmaceuticals Inc. - Common Stock reported net income of -9.68 M for the last quarter. The previous quarter showed -8.07 M, which means net income changed by -19.92%.

How many employees does Verrica Pharmaceuticals Inc. - Common Stock have?

As of the latest available data, Verrica Pharmaceuticals Inc. - Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.

What is Verrica Pharmaceuticals Inc. - Common Stock EBITDA?

Verrica Pharmaceuticals Inc. - Common Stock EBITDA is -9.6 M, and its EBITDA margin is -191.08%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Verrica Pharmaceuticals Inc. - Common Stock stock?

You can buy Verrica Pharmaceuticals Inc. - Common Stock (VRCA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Verrica Pharmaceuticals Inc. - Common Stock stock?

Investing in Verrica Pharmaceuticals Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VRCA chart and related analysis on metatrader.com as part of your research.

News